Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas. 1998

P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
Cardinal Bernardin Cancer Center and Department of Pathology, Loyola University of Chicago, Maywood, Illinois 60153, USA.

Pleural mesotheliomas and osteosarcomas develop in hamsters injected intracardially with SV40. Using primers specific for the RB-pocket binding domain of SV40 we analysed with the polymerase chain reaction frozen specimens from 48 human mesotheliomas and 145 human bone tumours. We found that 60% of human mesotheliomas and 33% of human bone tumours contained SV40-like DNA. Immunostaining, Western blot and RNA in situ hybridization experiments revealed SV40 Tag expression in human mesotheliomas. Osteosarcomas were not studied for Tag expression because not enough material was available. Finally, antibodies anti-Tag were detected in the sera collected from patients with mesothelioma. These data indicate that SV40, or a closely related virus, is/are present in human mesothelioma and osteosarcoma.

UI MeSH Term Description Entries
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D010997 Pleural Neoplasms Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms. Neoplasms, Pleural,Neoplasm, Pleural,Pleural Neoplasm
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D013539 Simian virus 40 A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures. SV40 Virus,Vacuolating Agent,Polyomavirus macacae,SV 40 Virus,SV 40 Viruses,SV40 Viruses,Vacuolating Agents
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection

Related Publications

P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
January 1996, Important advances in oncology,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
January 1998, Developments in biological standardization,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
January 1998, Developments in biological standardization,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
January 1998, Developments in biological standardization,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
August 1996, Oncogene,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
January 2004, Lancet (London, England),
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
May 1993, The American journal of pathology,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
April 1999, Journal of clinical pathology,
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
May 1989, Lancet (London, England),
P Rizzo, and I Di Resta, and R Stach, and L Mutti, and P Picci, and W M Kast, and H I Pass, and M Carbone
January 1998, Developments in biological standardization,
Copied contents to your clipboard!